Chemopreventive effects of a curcumin-like diarylpentanoid [2,6-bis(2,5-dimethoxybenzylidene)cyclohexanone] in cellular targets of rheumatoid arthritis in vitro

International Journal of Rheumatic Diseases

Volumn 18, Issue 6, 2015, Pages 616-627

  Lee, Ka Heng ^a   Abas, Faridah ^a   Mohamed Alitheen, Noorjahan Banu ^a   Shaari, Khozirah ^a   Lajis, Nordin Haji ^a   Israf, Daud Ahmad ^a   Syahida, Ahmad ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

BDMC33; Curcumin; HIG 82; Matrix metalloproteinase; NF B; Synovial fibroblast

Indexed keywords

COLLAGEN; COLLAGENASE; CURCUMIN; CYCLOHEXANONE DERIVATIVE; CYCLOOXYGENASE 2; CYTOKINE; DIARYLPENTANOID[2,6 BIS(2,5 DIMETHOXYBENZYLIDENE)CYCLOHEXANONE]; DNA; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG; 2,6-BIS(2,5-DIMETHOXYBENZYLIDENE)CYCLOHEXANONE; ANTIRHEUMATIC AGENT; AUTACOID; BENZYLIDENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CELL CULTURE; CHEMOPROPHYLAXIS; COLLAGEN DEGRADATION; CONTROLLED STUDY; DNA BINDING; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; FIBROBLAST; FLUORESCENCE ANALYSIS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; JOINT DESTRUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; CELL LINE; DOSE RESPONSE; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SYNOVIUM;

ANIMALS; ANTIRHEUMATIC AGENTS; BENZYLIDENE COMPOUNDS; CELL LINE; CYCLOHEXANONES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; INFLAMMATION MEDIATORS; MATRIX METALLOPROTEINASES; RABBITS; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TETRADECANOYLPHORBOL ACETATE;

EID: 84940037341     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12341     Document Type: Article

References (47)

1. Karouzakis E, Neidhart M, Gay RE, Gay S (2006) Molecular and cellular basis of rheumatois joint destruction. Immunol Lett 106, 8-13.
2. Mclnnes IB, Leung BP, Liew FY (2000) Cell-cell interaction in synovitis. Interaction between T lymphocytes and synovial cells. Arthritis Res 2, 364-78.
3. Tran CN, Lundy SK, Fox DA (2005) Synovial Biology and T cells in rheumatoid arthritis. Pathophysiology 12, 183-9.
4. Mor A, Abramson SB, Pillinger MH (2005) The fibroblast-like synovail cell in rheumatoid arthritis: a player in inflammation and joints destruction. Clin Immunol 115, 118-28.
5. Seemeyer CA, Neidhart M, Jungel A, Gay RE, Gay S (2005) Synovial fibroblast in joint destruction of rheumatoid arthritis. Drug Discov Today 2, 359-65.
6. Ritchlin C (2000) Fibroblast Biology: effector signals released by the synovial fibroblast in arthritis. Arthritis Res 2, 356-60.
7. Murphy G, Knäuper V, Atkinson S et al. (2002) Matrix metalloproteinases in arthritis disease. Arthritis Res 4, S39-49.
8. Benbow U, Brinckerhoff CE (1997) The AP-1 site and MMP gene regulation:what is all the fuss about? Matrix Biol 15, 519-26.
9. Vincenti MP, Brinckerhoff CE (2002) Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4, 157-64.
10. Makarov SS (2000) NF-κB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 6, 441-8.
11. Benito MJ, Murphy E, Murphy EP, van den Berg WB, FitzGerald O, Bresnihan B (2004) Increased synovial tissue NF-kappa B1 expression at sites adjacent to the cartilage pannus junction in rheumatoid arthritis. Arthritis Rheum 50, 1781-7.
12. Tomita T, Takano H, Tomita N, Morishita R, Kaneko M, Shi K (2000) Transcription factor decoy for NFκB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis. Rheumatology 39, 749-59.
13. McIntyr KW, Shuster DJ, Gillooly KM (2003) A highly selective inhibitor of IκB kinase, BMS-345542, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum 48, 2652-9.
14. Dieguez-Gonzalez R, Calaza M, Perez-Pampin E et al. (2009) Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-kappaB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility. Arthritis Res Ther 11, R42-50.
15. He Y, Xu H, Liang L et al. (2008) Anti inflammatory effect of Rho kinase blockade via inhibition of NF-kappaB activation in rheumatoid arthritis. Arthritis Rheum 58, 3366-76.
16. Adam BK, Ferstl EM, Davis MC et al. (2004) Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis. Bioorg Med Chem 12, 3871-83.
17. Wei QY, Ma JP, Cai YJ, Yang L, Liu ZL (2005) Cytotoxic and apoptotic activities of diarylheptanoids and gingerol-related compounds from the rhizome of Chinese ginger. J Ethnopharmacol 102, 177-84.
18. Weber WM, Hunsaker LA, Roybal N et al. (2006) Activation of NFκB is inhibited by curcumin and related enones. Bioorg Med Chem 14, 2450-61.
19. Chandru H, Sharada AC, Bettadaiah BK, Ananda Kumar CS, Rangappa KS, Sunila Jayashree K (2007) In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcumin analogs on mouse Ehrlich ascites tumor. Bioorg Med Chem 15, 7696-703.
20. Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30, 85-94.
21. Lee KH, Abdul Aziz FH, Syahida A et al. (2009) Synthesis and biological evaluation of curcumin-like diarylpentanoid analogues for anti-inflammatory, antioxidant and anti-tyrosinase activities. Eur J Med Chem 44, 3195-200.
22. Lee KH, Abas F, Alitheen NBM, Shaari K, Lajis NH, Ahmad S (2011) A curcumin derivative, 2, 6-bis(2, 5-dimethoxybenzylidene)-cyclohexanone (BDMC33) attenuates prostaglandin E2 synthesis via selective suppression of cyclooxygenase-2 in IFN-γ/LPS stimulated macrophages. Molecules 16, 9728-38.
23. Lee KH, Chow YL, Sharmili V et al. (2012) BDMC33, a curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: role of inhibition in NF-κB and MAPK signaling pathways. Int J Mol Sci 13, 2985-3008.
24. Lee YR, Lee JK, Noh EM et al. (2008) Guggulsterone blocks IL-1β-mediated inflammatory responses by suppressing NF-κB activation in fibroblast-like synoviocytes. Life Sci 82, 23-4.
25. Killeen ME, Englert JA, Stolz DB et al. (2006) The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells. J Pharmacol Exp Ther 316, 1070-9.
26. Kolomytkin OV, Marino AA, Waddell DD et al. (2002) IL-1β-induced production of metalloproteinases by synovial cells depends on gap junction conductance. Am J Physiol Cell Physiol 282, C1254-60.
27. So A, Chmot A, Peclat V, Gerster JC (1999) Serum MMP-3 in rheumatoid arthritis: correlation with systemic inflammation but not in erosive status. Rheumatology 19, 407-10.
28. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE (1996) Synovial fibroblast of patient with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 149, 1607-15.
29. Georgescu HI, Mendelow D, Evans CH (1988) HIG-82: an established cell line from rabbit periarticular soft tissue, which retains the "activatable" phenotype. In Vitro Cell Dev Biol 24, 1015-22.
30. Baeuerle PA, Henkel T (1994) Function and activation of NF-κB in the immune system. Ann Rev Immunol 12, 141-79.
31. Rowan AD (2001) Cartilage catabolism in arthritis: factors that influence homeostasis. Expert Rev Mol Med 3, 1-20.
32. Burger D, Rezzonico R, Li JM et al. (1998) Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblast upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis Rheum 41, 1748-59.
33. Manicourt DH, Fujimoto N, Obata K, Thonar EMA (1995) Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis: relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation. Arthritis Rheum 38, 1031-9.
34. 2. Evidence for a role of cyclooxgenase-2 and cytosolic phospholipase A2. J Immuol 155, 3570-7.
35. Chang YH, Lin IL, Tsay GT et al. (2008) Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Biochem 41, 955-9.
36. Moon D, Kim M, Choi YH, Park Y, Kim G (2010) Curcumin attenuates inflammatory response in IL-1β-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. Int Immunopharmacol 10, 605-10.
37. Woods JM, Mogollon A, Amin MA, Martinez RJ, Koch AE (2003) The role of COX-2 in angiogenesis and rheumatoid arthritis. Exp Mol Pathol 74, 282-90.
38. Wood NC, Symons JA, Dickens E, Duff GW (1992) In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol 87, 183-9.
39. Alonzi T, Fattori E, Lazzaro D et al. (1998) Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 187, 461-8.
40. Sasai M, Saeki Y, Ohshima S et al. (1999) Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum 42, 1635-43.
41. Patel AM, Moreland LW (2010) Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy. Drug Des Devel Ther 4, 263-78.
42. Gerlag DM, Ransone L, Tak PP et al. (2000) The effects of a T cell specific NF-{kappa}B inhibitor on the in vitro cytokine production and collagen-induced arthritis. J Immunol 165, 1652-8.
43. Sun Z, Anderson R (2002) NF-κB activation and inhibition: a review. SHOCK 18, 99-106.
44. Simmons DL, Botting RM, Hla T (2003) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56, 387-437.
45. Libermann TA, Baltimore D (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10, 2327-34.
46. Olivera A, Moore TW, Hu F et al. (2012) Inhibition of the NF-κB signaling pathway by the curcumin analog, 3, 5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol 12, 368-77.
47. Yan C, Boyd DD (2007) Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211, 19-26.